RxDoctor Payments Data

Donald Fong, MD

Ophthalmology · Baldwin Park, CANPI 1205907102

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $158,932 of the $158,997 with a category attached, or 100.0%. AbbVie accounts for 92.3% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2021 at $146,710 and has fallen 91.6% since, to $12,270 in 2024. Among ophthalmology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$158,997in general payments, 2019–2025

Across 6 payments — averaging $26,500 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$147K
  • Biocryst Pharmaceuticals, Inc.$12K
  • Carl Zeiss Meditec, Inc.$17
$129,404in research payments, 2019–2025

Across 2 payments — averaging $64,702 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$129K

What the payments were for

  • Consulting fees$158,932100%
  • Food & beverage$480%
  • Gifts$170%

General payments by program year

20
21
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie2$146,710
Biocryst Pharmaceuticals, Inc.3$12,270
Carl Zeiss Meditec, Inc.1$17

How this compares

$158,997 in reported general payments places this provider in the 95th percentile of 2,513 ophthalmology providers in California.

See all ophthalmology providers in California →

Medicare billing

Part B allowed, 2024
$9,055
Medicare patients
436
Services billed
439

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other ophthalmology in Baldwin Park

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →